Article Information
History
- August 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Simon Fink1,#,
- Felix Ruoff1,#,
- Aaron Stahl1,
- Matthias Becker1,
- Philipp Kaiser1,
- Bjoern Traenkle2,
- Daniel Junker1,
- Frank Weise1,
- Natalia Ruetalo3,
- Sebastian Hörber4,5,6,
- Andreas Peter4,5,6,
- Annika Nelde7,8,9,
- Juliane Walz7,8,9,10,
- Gérard Krause11,12,
- Katja Schenke-Layland1,9,13,14,
- Thomas Joos1,
- Ulrich Rothbauer1,2,
- Nicole Schneiderhan-Marra1,
- Michael Schindler3 and
- Markus F. Templin1,*
- 1NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
- 2Pharmaceutical Biotechnology, Eberhard-Karls-University, Tübingen, Germany
- 3Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany
- 4Central Laboratory, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany
- 5Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany
- 6German Center for Diabetes Research (DZD), München-Neuherberg, Germany
- 7Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany
- 8Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany
- 9Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tübingen, Tübingen, Germany
- 10Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany
- 11Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
- 12TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
- 13Department of Women’s Health, Research Institute for Women’s Health, Eberhard-Karls-University, Tübingen, Germany
- 14Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
- ↵*Corresponding author: Dr. Markus Templin, E-mail: templin{at}nmi.de
Posted August 04, 2020.
A throughput serological Western blot system using whole virus lysate for the concomitant detection of antibodies against SARS-CoV-2 and human endemic Coronaviridae
